Publication | Open Access

N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Medicinal ChemistryDrug TargetNovel SeriesBiochemistryMedicineNatural SciencesRational Drug DesignPharmacological AgentPharmacotherapyDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryDrug DiscoveryDrug Resistance